Stranded student helps design synthetic polymers to combat fungal infections
Every year, more than 2 million people are affected by invasive fungal infections, which are often caused by Candida species and are associated with high mortality rates. The development of new therapies is progressing very slowly. Demand is increasing, however, especially as drug resistance is becoming more and more common. An interdisciplinary research team led by Dr. Sascha Brunke from the Leibniz Institute for Natural Product Research and Infection Biology–Hans Knöll Institute (Leibniz-HKI) has now investigated the mode of action and therapeutic potential of synthetic polymers. These long-chain chemical compounds mimic naturally occurring peptides and inhibit the growth of microorganisms. The exact mechanism of action was previously unclear. However, the mystery has now been solved—all thanks to the coronavirus pandemic.
Read more.













